Log in or Sign up for Free to view tailored content for your specialty!
Asthma News
Persistent asthma may drive higher carotid plaque burden
Adults with persistent asthma, but not those with intermittent asthma, have a higher carotid plaque burden compared with those without asthma, according to research published in the Journal of the American Heart Association.
VIDEO: ‘Practical content,’ ‘real-world data’ part of CHEST 2022
Sandhya Khurana, MD, FCCP, spoke with Healio about key takeaways from the CHEST Annual Meeting that she plans to incorporate into her practice.
Log in or Sign up for Free to view tailored content for your specialty!
VIDEO: ‘Great asthma content’ presented at CHEST annual meeting
Sandhya Khurana, MD, FCCP, spoke with Healio about important highlights in the asthma space presented at CHEST 2022.
Moderate, severe asthma increases risk for ischemic heart disease
LOUISVILLE, Ky. — Patients with asthma had a greater risk for ischemic heart disease compared with those without asthma, according to speaker at the American College of Allergy, Asthma & Immunology Annual Scientific Meeting.
Tezepelumab use for 12 months lowers number of asthma exacerbations
LOUISVILLE, Ky. — Patients experienced fewer asthma exacerbations after taking tezepelumab for 12 months compared with the 12 months prior to treatment, according to study results.
VIDEO: ‘Important,’ ‘timely’ discussion on burden of corticosteroid-dependent asthma
In a video interview, Sandhya Khurana, MD, FCCP, spoke with Healio about a session she participated in regarding corticosteroid-dependent asthma at the CHEST Annual Meeting.
Albuterol-budesonide decreases asthma deteriorations, exacerbations
LOUISVILLE, Ky. — Patients treated with albuterol and budesonide experienced less asthma deteriorations and exacerbations over 12 weeks compared with patients who received the mono-components or placebo, according to DENALI study results.
Tezepelumab only biologic to consistently reduce exacerbations in severe allergic asthma
LOUISVILLE, Ky. — Of approved biologics for severe, allergic asthma, tezepelumab was the only one to consistently reduce the annualized exacerbation rate across patient subgroups, according to a literature review.
Liability concerns represent roadblock to stocking albuterol inhalers in schools
LOUISVILLE, Ky. — Liability concerns prevent stakeholders from adequately stocking albuterol inhalers in Illinois schools, according to a poster presented at the American College of Allergy, Asthma & Immunology Annual Scientific Meeting.
Sexual intercourse may trigger asthma exacerbations
LOUISVILLE, Ky. — Much like exercise-induced asthma, sexual intercourse can also trigger asthma exacerbations, according to study results presented at the American College of Allergy, Asthma & Immunology Annual Scientific Meeting.
-
Headline News
‘We have a home’: Physician aims to create network of women allergists
November 14, 20245 min read -
Headline News
Diversified portfolios allow for ‘smoother ride’
November 14, 20243 min read -
Headline News
Predelivery concussion linked to increased risk for severe maternal mental illness
November 12, 20242 min read
-
Headline News
‘We have a home’: Physician aims to create network of women allergists
November 14, 20245 min read -
Headline News
Diversified portfolios allow for ‘smoother ride’
November 14, 20243 min read -
Headline News
Predelivery concussion linked to increased risk for severe maternal mental illness
November 12, 20242 min read